Cipla informs about press release

13 Nov 2018 Evaluate

Cipla has informed about the Press Release on acquisition of specialty business in USA. The details as required pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, are enclosed as Annexure I. In terms of the Company's Code of Conduct for Prevention of Insider Trading, the ‘Trading Window’ for dealing in the securities of the Company has been closed from 7th November 2018 and will open for trading on 15th November 2018.

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1326.00 13.35 (1.02%)
05-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.90
Dr. Reddys Lab 1313.05
Cipla 1326.00
Zydus Lifesciences 914.45
Lupin 2332.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×